Zhenguo Cheng

Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

Pengju Wang, Xiaozhu Li, Jiwei Wang et al. · Nature Communications · 2017 · 173 citations · Full text

Engineered bacterial outer membrane vesicles encapsulating oncolytic adenoviruses enhance the efficacy of cancer virotherapy by augmenting tumor cell autophagy

Weiyue Ban, Mengchi Sun, Hanwei Huang et al. · Nature Communications · 2023 · 88 citations · Full text

Boarding Oncolytic Viruses onto Tumor-Homing Bacterium-Vessels for Augmented Cancer Immunotherapy

Mengchi Sun, Shihua Yang, Hanwei Huang et al. · Nano Letters · 2022 · 67 citations

miR-133 is a key negative regulator of CDC42–PAK pathway in gastric cancer

Zhenguo Cheng, Funan Liu, Guanqiao Wang et al. · Cellular Signalling · 2014 · 58 citations

Tumor Biology, Medicine, Key Negative Regulator +10

Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis

Chengli Wang, Y Li, H Zhang et al. · Oncogene · 2013 · 57 citations

Medicine, Pathology, Tumor Suppressor +6